Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by GeneCure Biotechnologies
Information provided by (Responsible Party):
GeneCure Biotechnologies Identifier:
First received: September 1, 2011
Last updated: March 9, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):